Amiprilose

Drug Profile

Amiprilose

Alternative Names: KAP 690; SM 1213; Therafectin

Latest Information Update: 31 May 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Boston Life Sciences
  • Class Anti-inflammatories; Antirheumatics; Hexosamines; Monosaccharides; Small molecules
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 31 May 2002 Discontinued - Preregistration for Rheumatoid arthritis in France (PO)
  • 31 May 2002 Discontinued - Preregistration for Rheumatoid arthritis in Ireland (PO)
  • 31 May 2002 Discontinued - Preregistration for Rheumatoid arthritis in Netherlands (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top